Highline Wealth Partners
PJP icon

Highline Wealth Partners’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Highline Wealth Partners’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.4K Hold
84
– – ﹤0.01% 681
2026
Q2 		$9.9K Buy
+84
New +$9.09K ﹤0.01% 602

Other funds holding PJP

HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
Affinity Wealth Management
Affinity Wealth Management Wilmington, Delaware $740M AUM 34.87% 1-Year Est. Return
Beacon Harbor Wealth Advisors
Beacon Harbor Wealth Advisors Virginia Beach, Virginia $526M AUM 34.64% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Trek Financial
Trek Financial Scottsdale, Arizona $2.16B AUM 42.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vicus Capital
Vicus Capital State College, Pennsylvania $1.58B AUM 16.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Joseph Group Capital Management
Joseph Group Capital Management Columbus, Ohio $562M AUM 15.17% 1-Year Est. Return

Highline Wealth Partners's PJP Position: Q3 2026 in Review

Highline Wealth Partners held its Invesco Pharmaceuticals ETF (PJP) position steady in Q3 2026 at 84 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #681.

Highline Wealth Partners first reported a position in PJP in Q2 2026 and has held it in 2 quarters since. 97 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

  • Highline Wealth Partners held 84 shares of Invesco Pharmaceuticals ETF worth $10.4K as of Q3 2026.
  • Highline Wealth Partners left its Invesco Pharmaceuticals ETF share count unchanged in Q3 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #681 holding.
  • Highline Wealth Partners first reported a position in Invesco Pharmaceuticals ETF in Q2 2026 and has held it in 2 quarters since.
  • 97 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.